v3.25.4
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity
A summary of the Company's stock options activity for the nine months ended December 31, 2025 is presented below:
Number of Stock
Options
Weighted Average
Exercise
Price
Weighted Average
Remaining Contractual
Life (Years)
Total Intrinsic
Value
Outstanding as of March 31, 2025
1,356 $16.68 3.31$— 
Granted, at fair market value150 6.20 9.38
Exercised— — — 
Forfeited or expired— — — 
Outstanding as of December 31, 2025
1,506 $15.63 3.24$— 
Exercisable as of December 31, 2025
1,356 $16.68 2.56$— 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions No options were granted during the three months ended December 31, 2025 or during the three and nine months ended December 31, 2024.
Nine Months Ended December 31, 2025
Weighted-average fair value of options granted$3.40 
Weighted-average assumptions used:
Expected volatility51.7 %
Expected dividend yield0.0 %
Expected life6.25 years
Risk-free rate4.18 %
Exercise price$6.20 
Schedule of Restricted Stock and Restricted Stock Units
A summary of the Company's restricted stock and restricted stock unit awards activity for the nine months ended December 31, 2025 is presented below: 
Number of
Restricted Shares
Weighted Average
Grant Date Fair Value
Outstanding as of March 31, 2025
22,976 $7.58 
Granted9,288 6.06 
Forfeited(1)
(8,864)8.26 
Vested(6,167)8.22 
Outstanding as of December 31, 2025
17,233 $5.57 
(1) Includes 0.5 million of performance-based restricted stock units awarded to certain executives and key employees under the 2005 Plan during Fiscal 2023, which have been fully forfeited due to the failure to meet the financial performance conditions.